MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
5.03
-0.07 (-1.37%)
At close: Mar 28, 2025, 4:00 PM
5.06
+0.03 (0.65%)
After-hours: Mar 28, 2025, 7:50 PM EDT
MannKind Revenue
In the year 2024, MannKind had annual revenue of $285.50M with 43.50% growth. MannKind had revenue of $76.78M in the quarter ending December 31, 2024, with 31.30% growth.
Revenue (ttm)
$285.50M
Revenue Growth
+43.50%
P/S Ratio
4.83
Revenue / Employee
$701,484
Employees
407
Market Cap
1.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 285.50M | 86.54M | 43.50% |
Dec 31, 2023 | 198.96M | 99.19M | 99.42% |
Dec 31, 2022 | 99.77M | 24.33M | 32.25% |
Dec 31, 2021 | 75.44M | 10.30M | 15.81% |
Dec 31, 2020 | 65.14M | 2.11M | 3.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMNKD News
- 18 days ago - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - GlobeNewsWire
- 4 weeks ago - MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question - Seeking Alpha
- 4 weeks ago - MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025 - GlobeNewsWire
- 7 weeks ago - MoneyShow's Best Investment Ideas For 2025: Part 8 - Seeking Alpha
- 2 months ago - MannKind Expands Executive Leadership Team - GlobeNewsWire
- 3 months ago - MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets - Seeking Alpha